PulseAugur
LIVE 21:08:44
ENTITY GenSci161

GenSci161

PulseAugur coverage of GenSci161 — every cluster mentioning GenSci161 across labs, papers, and developer communities, ranked by signal.

Total · 30d
1
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TIMELINE
  1. 2026-05-15 research_milestone GenSci161 injection receives FDA approval for clinical trials in the US for hidradenitis suppurativa. source
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL
  1. TOOL · CL_33216 ·

    Changchun High-Tech subsidiary's drug gets FDA nod for US clinical trials

    Changchun High-Tech's subsidiary, Gensci Pharmaceutical, has received approval from the U.S. FDA to commence clinical trials for its GenSci161 injection. This fully human bispecific antibody targets both IL-1α and IL-1β…